Skip to main content

Navigation group

Type at least 3 characters
1,021 articles

Articles

Original Research

Published on 23 Jun 2022

B Lymphocytes Are a Predictive Marker of Eribulin Response and Overall Survival in Locally Advanced or Metastatic Breast Cancer: A Multicenter, Two-Cohort, Non-Randomized, Open-Label, Retrospective Study

in Breast Cancer

  • Liubov A. Tashireva
  • Nataliya O. Popova
  • Anna Yu. Kalinchuk
  • Viktor E. Goldberg
  • Elena I. Kovalenko
  • Elena V. Artamonova
  • Aleksey G. Manikhas
  • Dmitriy M. Ponomarenko
  • Nataliya V. Levchenko
  • Elena I. Rossokha
B Lymphocytes Are a Predictive Marker of Eribulin Response and Overall Survival in Locally Advanced or Metastatic Breast Cancer: A Multicenter, Two-Cohort, Non-Randomized, Open-Label, Retrospective Study
Frontiers in Oncology
doi 10.3389/fonc.2022.909505
  • 1,286 views
  • 2 citations